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Abstract
Background In a previous controlled study, we investi-
gated the relationship between Bordetella pertussis infec-
tions and sudden unexpected deaths among German infants
(sudden infant death syndrome, SIDS). In this present
study, we investigated further the respiratory pathology in a
subset of infants in the original study.
Methods Originally, there were 234 infants with SIDS and,
of these, 12 had either a nasopharyngeal swab (NPS) or a
tracheal swab specimen (TS) that was positive for B. per-
tussis by polymerase chain reaction (PCR). Here, tissue
specimens from eight infants who were originally PCR-
positive were compared with tissue specimens from seven
infants in whom the original PCR studies were negative.
Results The histopathologic diagnoses were as follows:
14 of 15 had pulmonary edema and the remaining case had
early diffuse alveolar damage. Although 14 of 15 cases had
some histologic or clinical evidence suggesting respiratory
tract infection, the features were more consistent with a
viral etiology, and in none were the findings typical of
respiratory disease attributable to B. pertussis.
Conclusions The findings in this present investigation do
not support a direct role of B. pertussis at the site of
infection (ciliated epithelium) in the causation of SIDS.
The clinical aspects of this study were carried out in the
1990s when pertussis was widespread in Germany.
Therefore, the original finding of some PCR-positive cases
is not surprising. The possibility that B. pertussis infection
could still be a factor in some SIDS cases, e.g., by a sys-
temic release of toxins, cannot be definitely ruled out.
Keywords Bordetella pertussis  Sudden unexpected
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Introduction
In the past, it was noted in Sweden, Norway, and England
and Wales that infant deaths diagnosed as sudden infant
death syndrome (SIDS) increased when pertussis was epi-
demic in the population [1, 2]. Almost two decades ago, we
carried out Bordetella pertussis polymerase chain reaction
(PCR) studies in Germany on nasopharyngeal swab (NPS)
specimens from 51 infants with sudden deaths and nine
(18%) were B. pertussis-positive [3]. A weakness of this
initial investigation was that clinical information on
respiratory illnesses prior to death had not been carefully
obtained.
Between 1995 and 1997, we then carried out a pro-
spective controlled study to investigate the relationship
between B. pertussis infections and SIDS among German
infants [4]. In that study, NPS or tracheal swab (TS)
specimens were obtained for B. pertussis PCR from 234
infants and from 441 matched control infants. The PCR
results were positive for B. pertussis in 12 (5.1%) of the
case subjects and from 5.3% of control subjects. In a more
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recent study, we studied the pathology of fatal infant per-
tussis using immunohistochemistry and molecular tech-
niques [5].
Based on this previous experience, we have looked
further for a possible causal relationship between B. per-
tussis infection and SIDS in this present investigation. To
do this, we evaluated the histopathologic features and
employed an immunohistochemical (IHC) stain in the tra-
chea, larynx, bronchi, and lungs in cases of sudden unex-
pected deaths, from our 1995–1997 study, in whom PCR
specimens were positive or negative for B. pertussis.
Methods
For this investigation, institutes for legal medicine who, in
the original study [4], had contributed at least one B. per-
tussis PCR-positive case subject were contacted and asked
for the available lower respiratory tract autopsy specimens
from these overall 12 cases. In addition, for each PCR-
positive case, lower respiratory tract autopsy specimens
were requested from B. pertussis PCR-negative subjects
from the same study to serve as controls.
Formalin-fixed, paraffin-embedded respiratory tissues
from these German infants who died during 1995–1997
from SIDS were evaluated at the Centers for Disease
Control and Prevention (CDC). Tissue samples
were stained at the CDC by using hematoxylin and eosin
and by an immunoalkaline phosphate technique with a
monoclonal antibody which reacts to lipooligosaccharide A
of B. pertussis (IHC staining) [5].
In the original German study, SIDS was described as
‘‘sudden infant death which was unexpected by history and
in which the autopsy fails to demonstrate an adequate cause
of death’’. The initial study protocol was approved by the
ethics committee of the University of Erlangen (Erlangen,
Germany).
Results
Respiratory specimens were received from 8 of 12 infants
that had NPS or TS specimens taken at the time of autopsy
who tested positive and seven specimens were received
from deceased infants who had tested negative for B. per-
tussis by PCR [4]. Fourteen of the 15 infant deaths in
whom tissue specimens were evaluated at the CDC were
initially diagnosed as SIDS by the German pathologists.
Presented in Tables 1 and 2 are the histopathologic find-
ings and the pathologic opinions at the CDC and the
descriptive findings of the German pathologists and reports
by parents when available. In Table 1, the findings in the
eight cases who had initial NPS or TS B. pertussis PCR-
positive samples in Germany are presented and in Table 2,
similar findings for the seven cases that were B. pertussis
PCR-negative in Germany are presented.
In Figs. 1 and 2, selected histopathologic findings in the
tissues examined at the CDC from initially PCR-positive
Table 1 Histopathology and pathologic diagnosis in eight infants with sudden death in whom initial nasopharyngeal swab (NPS) or tracheal
swab (TS) samples were positive for Bordetella pertussis by polymerase chain reaction (PCR)
Case
no.
Data from the CDC laboratory German pathologic diagnosis
and clinical data
Histopathology Pathologic Dx
237/95 Trachea: focal, mild submucosal mononuclear inflammation. Lung:
diffuse intraalveolar edema
Mild tracheitis and
pulmonary edema
SIDS plus respiratory tract
infection; bilateral otitis
media
148/96 Trachea: no significant histopathology. Larynx: focal mild submucosal
inflammation. Lung: patchy intraalveolar edema
Pulmonary edema SIDS plus respiratory tract
infection
374/96 Trachea, larynx, and bronchi: extensive mixed submucosal inflammatory
cell infiltrates and focal ulceration. Lung: diffuse intraalveolar edema
Pulmonary edema SIDS plus laryngotracheitis
and bronchitis
174/95 Lung: diffuse intraalveolar edema Pulmonary edema SIDS. onset of rhinitis and
cough
863/95 Bronchi: focally denuded mucosa without significant inflammation.
Lungs: patchy intraalveolar edema
Pulmonary edema SIDS plus mild signs of
respiratory tract infection
1216/95 Trachea: no significant inflammation. Lung: multifocal interstitial
pneumonitis and diffuse intraalveolar edema with scattered colonies of
large bacterial rods (postmortem?)
Interstitial pneumonitis
and pulmonary edema
Brain edema
1221/95 Trachea: no significant inflammation. Lung: diffuse intraalveolar edema Pulmonary edema SIDS plus mild signs of
respiratory tract infection;
cough
128/95 Trachea and bronchi: multifocal submucosal inflammatory cell infiltrates
and mucosal denudation. Lung: diffuse intraalveolar edema
Tracheobronchitis and
pulmonary edema
SIDS plus severe respiratory
tract infection
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and PCR-negative infants are presented. No remarkable
differences were noted between the pathologic findings of
the eight cases with initially B. pertussis PCR-positive
findings and those of the seven cases in whom the initial
PCR studies were negative. In all but one case pulmonary
edema was the major finding. Interestingly, the pathologic
Table 2 Histopathology and pathologic diagnosis in seven infants with sudden death in whom initial nasopharyngeal swab (NPS) or tracheal
swab (TS) were negative for Bordetella pertussis by polymerase chain reaction (PCR)
Case
no.
Data from the CDC laboratory German pathologic diagnosis
and clinical data
Histopathology Pathologic Dx
342/95 Trachea: multifocally denuded mucosa, with focal mild inflammation. Lung:
diffuse intraalveolar edema
Mild tracheitis and
pulmonary edema
SIDS plus respiratory tract
infection; food aspiration
31/96 Trachea: no significant histopathology. Lung: patchy intraalveolar edema Pulmonary edema SIDS plus respiratory tract
infection
18/97 Trachea and larynx: multifocal mucosal ulceration with mild focal submucosal
inflammation. Lung: patchy intraalveolar edema
Mild tracheitis and
pulmonary edema
SIDS plus respiratory tract
infection
268/95 Bronchi: extensively denuded mucosa without significant inflammation.
Lungs: intraalveolar hemorrhage and macrophages, suggestive of early
diffuse alveolar damage
Early diffuse
alveolar damage
SIDS plus mild respiratory
tract infection
1024/95 Trachea: no significant histopathology. Lung: patchy intraalveolar edema Pulmonary edema SIDS plus mild respiratory
tract infection
1888/95 Bronchi: multifocal mucosal ulceration with mild focal submucosal
inflammation. Lung: patchy intraalveolar edema
Bronchitis and
pulmonary edema
SIDS plus interstitial
pneumonia; hepatitis
1940/95 Lung: diffuse intraalveolar edema Pulmonary edema SIDS
Fig. 1 Histopathologic findings of selected infants from Table 1.
a Extensive intraalveolar edema. b Focal, mild, predominantly
mononuclear inflammatory cell infiltrates in the lamina propria of
the trachea. c Abundant lymphoplasmacytic inflammatory cell
infiltrates in the lamina propria of the trachea with prominent
submucosal congestion. d Trachea with no significant inflammatory
cell infiltrates
Fig. 2 Histopathologic findings of selected subjects from Table 2.
a Bronchus with extensively denuded and necrotic mucosal epithe-
lium without conspicuous inflammatory cell infiltrates. b Lung with
early diffuse alveolar damage characterized by intraalveolar
macrophages and fibrin, and interstitial and intraalveolar edema.
c Mild, predominantly mononuclear inflammatory cell infiltrates in
the submucosa of the bronchus, with patchy loss of epithelium.
d Extensive intraalveolar edema
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findings in three cases (three in the PCR-positive group and
three in the PCR-negative group) had findings suggestive
of a respiratory viral infection. Of the eight cases who were
initially PCR-positive, in addition to pulmonary edema,
two had tracheobronchitis, one had mild tracheitis, and one
had interstitial pneumonitis. Of the seven cases who were
initially PCR-negative, two had mild tracheitis, one had
bronchitis, and one had early diffuse alveolar damage.
Of note, IHC staining for B. pertussis was negative in all
specimens. In none of the 15 cases were there typical
findings of fatal pertussis (pulmonary hemorrhage, septal
edema, necrotizing bronchopneumonia, and leukocyte
aggregates in septal and pleural veins and lymphatics) [5].
Discussion
The clinical aspects of this study were carried out when
pertussis was widespread in Germany, so that finding some
PCR-positive cases is not surprising, as asymptomatic or
mild infections with B. pertussis are common [4, 6, 7].
Importantly, there were no apparent differences in the
histopathologic findings between cases that were initially
either PCR-positive or PCR-negative.
Although all but one of the 15 cases had some evidence
of respiratory tract infection, in none was it typical of fatal
B. pertussis infection, i.e., in none of the infants was there
evidence of a descending lower respiratory tract infection
dominated by necrotizing bronchiolitis, fibrinous edema, or
prominent angiolymphatic collections of leukocytes [5].
Rather, the histopathological findings were most consistent
with a mild viral infection.
In light of these histopathologic findings, the data from
this study does not support a direct role of B. pertussis at
the site of infection (ciliated epithelium) in the causation of
SIDS. However, since it has been noted that reported SIDS
increases during epidemic pertussis [1, 2] and since
B. pertussis DNA has been found in respiratory specimens
in infants with sudden unexplained deaths [3, 4], it is
possible that the B. pertussis infection could still be a factor
in SIDS through the systemic release of toxin or toxins. In
this regard, pertussis toxin (PT) would seem to be a pos-
sibility, since it can cause hypoglycemia [8], but if PT were
the cause, one might expect to see signs of the associated
leukocytosis with lymphocytosis in the histological
specimens from the respiratory tract, which was not the
case in our investigations. Although the cause of the par-
oxysmal cough in pertussis is not known, it is presumed to
be one or more toxins that mediate cough through a central
nervous system site [8]. SIDS could be an outcome from
apnea (a characteristic complication in infants with per-
tussis) resulting from toxin effects in B. pertussis-infected
infants.
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